跳至主要内容
临床试验/NCT01553240
NCT01553240终止不适用

Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies

New York State Psychiatric Institute1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2007年6月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
8
试验地点
1
主要终点
Repetitive Behavior Scale-revised

研究概览

简要总结

This study uses functional brain imaging and noninvasive brain stimulation techniques to study the brain basis of developmental disorders like Autism Spectrum Disorder and Asperger Disorder. Functional magnetic resonance imaging (fMRI) and recently approved FDA treatment of depression, Transcranial magnetic stimulation (TMS) will be used to study the neurocircuitry of certain symptom clusters in developmental disorders.

详细描述

The purpose of this research is to study areas of the brain that may have something to do with repetitive movements (things that people do over and over again) and difficulty communicating with other people (problems with talking to, understanding, or just being in a relationships with other people). The investigators are trying to find out why these brain areas are working differently in people with developmental disorders, such as Autism and how the investigators can one day improve them with new brain stimulation techniques.

The investigators will do screening to make sure that you are eligible for the study. After screening, the investigators will do functional MRI. In this procedure the subject or the control will be looking at videos developed to understand their social communication and language skills. The investigators will be able to understand differences of brain activation between patients and control. The investigators will also use TMS to identify the difference of motor excitability between patients and healthy control.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • for Healthy volunteer:
  • no current psychiatric disorder meeting Axis 1 DSM-4 criteria.
  • English speaking,
  • verbal and full scale IQ > 65,
  • capacity to give consent and signed HIPPA authorization.
  • for Autism Spectrum Disorders:
  • diagnosed with Autism, Asperger or Pervasive Developmental Disorder not otherwise specified,
  • English speaking,
  • capacity to give consent and verbal and full scale IQ > 65,
  • signed HIPPA authorization,
  • participants currently taking psychotropic medications must be at the same stable doses and be willing to continue at the same dose through out the study

排除标准

  • for Healthy control and ASD:
  • women of child bearing potential not using birth control pills or breast feeding,
  • h/o bipolar disorder (lifetime),
  • any psychotic disorder( lifetime),
  • history of major depressive disorder or of substance abuse or dependence within the past year,
  • verbal or full scale IQ less than or equal to 65,
  • intracranial implants,
  • metallic implants,
  • shrapnel in the body,
  • metallic braces,
  • cardiac pacemakers or
  • vagus nerve stimulation device,
  • claustrophobia,
  • prior dx of seizure,
  • increased intracranial pressure or history of significant head trauma with loss of consciousness for at least 5 minutes
  • current significant laboratory abnormality,
  • neurological disorder including but not limited to space occupying brain lesion,
  • any history of seizures,
  • history of cerebrovascular accidents,
  • fainting,
  • cerebral aneurysm,
  • dementia,
  • huntington,
  • multiple sclerosis

结局指标

主要结局

Repetitive Behavior Scale-revised

时间窗: during screening

次要结局

  • Vineland Maladaptive Behavior Scale(during screening)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Neurocircuitry of Autism- fMRI and Transcranial... | 临床试验